Afya Limited - Class A Common Shares (AFYA): Price and Financial Metrics
GET POWR RATINGS... FREE!
AFYA POWR Grades
- Sentiment is the dimension where AFYA ranks best; there it ranks ahead of 87.32% of US stocks.
- AFYA's strongest trending metric is Stability; it's been moving up over the last 206 days.
- AFYA's current lowest rank is in the Value metric (where it is better than 12.98% of US stocks).
AFYA Stock Summary
- AFYA's went public 1.82 years ago, making it older than only 2.93% of listed US stocks we're tracking.
- With a year-over-year growth in debt of 136.17%, Afya Ltd's debt growth rate surpasses 92.16% of about US stocks.
- Afya Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -36.56%, greater than the shareholder yield of only 7.62% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Afya Ltd, a group of peers worth examining would be ACB, ADMA, NESR, BBCP, and CDE.
- AFYA's SEC filings can be seen here. And to visit Afya Ltd's official web site, go to www.afya.com.br.
AFYA Price Target
For more insight on analysts targets of AFYA, see our AFYA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $26.57 | Average Broker Recommendation | 1.64 (Moderate Buy) |
AFYA Stock Price Chart Interactive Chart >
AFYA Price/Volume Stats
| Current price | $23.05 | 52-week high | $29.01 |
| Prev. close | $23.17 | 52-week low | $16.85 |
| Day low | $22.85 | Volume | 181,900 |
| Day high | $23.91 | Avg. volume | 231,036 |
| 50-day MA | $21.50 | Dividend yield | N/A |
| 200-day MA | $24.17 | Market Cap | 2.15B |
Afya Limited - Class A Common Shares (AFYA) Company Bio
Afya Ltd. is a medical education group in Brazil. It delivers an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs and continuing medical education activities. The company operates through the following two segments: Education Services and Residency Preparatory & Specialization Programs. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences and other undergraduate programs. The Residency Preparatory & Specialization Programs segment provides residency preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education platform and practical medical training. Afya was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.
Latest AFYA News From Around the Web
Below are the latest news stories about Afya Ltd that investors may wish to consider to help them evaluate AFYA as an investment opportunity.
Afya Limited Announces the Acquisition of ShospNOVA LIMA, MINAS GERAIS, Brazil, May 13, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced the acquisition of 100% of the total share capital of Shosp, a clinical management software that offers all functionalities needed for clinics all over Brazil to manage their financials, patients appointments, medical records, marketing, and others. Shosp as of today has more than 450 clinics associated with 2,800 monthly active users, of which 1,937 are monthly active subscribers, with more than 3 million consultations since inception, generating an ARR (Annual Recurring Revenue) of R$ 1.8 million. Shosp users will be migrated to iClinic’s platform to create a unique offering of clinical management software and Shosp team will join Afya’s digital capabilities to contri... |
Afya Announces Closing of $150 Million Investment from the SoftBank Latin America FundNOVA LIMA, MINAS GERAIS, Brazil, May 03, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), the largest medical education group in Brazil, today announced that SoftBank Latin America Fund (“Softbank”) closed on its purchase of US$150 million of Afya’s Series A perpetual convertible preferred shares set forth in the Certificate of Designations. In addition, Crescera Educacional II Fundo de Investimento em Participações Multiestratégia and the Esteves Family also closed on the sale of 2,270,208 Class A common shares to SoftBank. In connection with such sale, Paulo Passoni from Softbank will be appointed as a board member of Afya within the next 30 days. Softbank and its affiliates beneficially own approximately 8.4% of the total shares of the company (on an as-converted basis ... |
Afya Limited to Report First Quarter 2021 Financial Results on May 27NOVA LIMA, MINAS GERAIS, Brazil, May 03, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report first quarter 2021 financial results for the period ended March 31, 2021, following the close of the market on Thursday, May 27, 2020. The Company will host a corresponding conference call and webcast on May 28 at 11:00 AM EDT. Dialing numbers for the conference will be disclosed soon. A live and archived webcast of the call will be available on the Investor Relations section of the Company’s website at https://ir.afya.com.br/. About Afya Limited (Nasdaq: AFYA) Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students to be lifel... |
SoftBank funding propels U.S. shares of Brazil's Afya to near three-month highThe investment will be executed through the purchase of convertible preferred shares, Afya said, with SoftBank Group Corp also planning to buy about 2.2 million common shares of the company from two existing shareholders. Based on the closing price of the stock on Monday, this would represent an additional investment of around $50 million. Afya, which acquired iClinic earlier this year, provides medical education services to students in Brazil and debuted on the Nasdaq in 2019. |
Afya Announces a $150 Million Investment from the SoftBank Latin America FundNOVA LIMA, Brazil and MINAS GERAIS, Brazil, April 27, 2021 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), the largest medical education group in Brazil, today announced that the SoftBank Latin America Fund (“Softbank”) has agreed to purchase R$822 million, equivalent to $150 million, of Afya’s Series A perpetual convertible preferred shares set forth on the Certificate of Designations, subject to customary closing conditions. In addition, Crescera Educacional II Fundo de Investimento em Participações Multiestratégia and the Esteves Family have agreed to sell 2,270,208 Class A common shares to SoftBank. In connection with such sale, Paulo Passoni from Softbank will be appointed as a board member of Afya within the next 30 days. SoftBank and its affiliates will beneficially own... |
AFYA Price Returns
| 1-mo | 0.09% |
| 3-mo | -2.50% |
| 6-mo | -15.40% |
| 1-year | 15.77% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -8.89% |
| 2020 | -6.71% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...